Table 4 Summary of HRs for the two scenarios
Scenario | Drugs to be compared (N) number of cases with event (%) | Adjusted HR [95% CI] (p-value) | |
|---|---|---|---|
1. Oxaliplatin vs cisplatin for PN | Oxaliplatin (N = 630) | Cisplatin (N = 630) | 3.28 [2.79, 3.85] (<0.001) |
519 (82.4) | 284 (45.1) | ||
2. Docetaxel vs paclitaxel for OM | Docetaxel (n = 704) | Paclitaxel (n = 704) | 2.34 [1.91, 2.88] (<0.001) |
296 (42.0) | 147 (20.9) | ||
